175 related articles for article (PubMed ID: 18331150)
21. Interval estimation of the proportion ratio in repeated binary measurements under a stratified randomized clinical trial with noncompliance.
Lui KJ; Chang KC
J Biopharm Stat; 2012; 22(1):109-32. PubMed ID: 22204530
[TBL] [Abstract][Full Text] [Related]
22. Estimating causal effects from a randomized clinical trial when noncompliance is measured with error.
Boatman JA; Vock DM; Koopmeiners JS; Donny EC
Biostatistics; 2018 Jan; 19(1):103-118. PubMed ID: 28605411
[TBL] [Abstract][Full Text] [Related]
23. Statistical analysis and handling of missing data in cluster randomized trials: a systematic review.
Fiero MH; Huang S; Oren E; Bell ML
Trials; 2016 Feb; 17():72. PubMed ID: 26862034
[TBL] [Abstract][Full Text] [Related]
24. Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data.
Chen H; Geng Z; Zhou XH
Biometrics; 2009 Sep; 65(3):675-82. PubMed ID: 18759847
[TBL] [Abstract][Full Text] [Related]
25. Analysis and reporting of stratified cluster randomized trials-a systematic survey.
Borhan S; Papaioannou A; Ma J; Adachi J; Thabane L
Trials; 2020 Nov; 21(1):930. PubMed ID: 33203468
[TBL] [Abstract][Full Text] [Related]
26. Bounds on causal effects in randomized trials with noncompliance under monotonicity assumptions about covariates.
Chiba Y
Stat Med; 2009 Nov; 28(26):3249-59. PubMed ID: 19777494
[TBL] [Abstract][Full Text] [Related]
27. Test non-inferiority and sample size determination based on the odds ratio under a cluster randomized trial with noncompliance.
Lui KJ; Chang KC
J Biopharm Stat; 2011 Jan; 21(1):94-110. PubMed ID: 21191857
[TBL] [Abstract][Full Text] [Related]
28. Test homogeneity of odds ratio in a randomized clinical trial with noncompliance.
Lui KJ; Chang KC
J Biopharm Stat; 2009 Sep; 19(5):916-32. PubMed ID: 20183452
[TBL] [Abstract][Full Text] [Related]
29. Sample size requirements for testing treatment effect heterogeneity in cluster randomized trials with binary outcomes.
Maleyeff L; Wang R; Haneuse S; Li F
Stat Med; 2023 Nov; 42(27):5054-5083. PubMed ID: 37974475
[TBL] [Abstract][Full Text] [Related]
30. A causal model for longitudinal randomised trials with time-dependent non-compliance.
Becque T; White IR; Haggard M
Stat Med; 2015 May; 34(12):2019-34. PubMed ID: 25778798
[TBL] [Abstract][Full Text] [Related]
31. An overview of statistical methods for handling nonadherence to intervention protocol in randomized control trials: a methodological review.
Mostazir M; Taylor RS; Henley W; Watkins E
J Clin Epidemiol; 2019 Apr; 108():121-131. PubMed ID: 30528792
[TBL] [Abstract][Full Text] [Related]
32. Treatment noncompliance in randomized experiments: statistical approaches and design issues.
Sagarin BJ; West SG; Ratnikov A; Homan WK; Ritchie TD; Hansen EJ
Psychol Methods; 2014 Sep; 19(3):317-33. PubMed ID: 24773358
[TBL] [Abstract][Full Text] [Related]
33. Increased risk of type I errors in cluster randomised trials with small or medium numbers of clusters: a review, reanalysis, and simulation study.
Kahan BC; Forbes G; Ali Y; Jairath V; Bremner S; Harhay MO; Hooper R; Wright N; Eldridge SM; Leyrat C
Trials; 2016 Sep; 17(1):438. PubMed ID: 27600609
[TBL] [Abstract][Full Text] [Related]
34. An extended general location model for causal inferences from data subject to noncompliance and missing values.
Peng Y; Little RJ; Raghunathan TE
Biometrics; 2004 Sep; 60(3):598-607. PubMed ID: 15339281
[TBL] [Abstract][Full Text] [Related]
35. Bias analysis of the instrumental variable estimator as an estimator of the average causal effect.
Chiba Y
Contemp Clin Trials; 2010 Jan; 31(1):12-7. PubMed ID: 19879376
[TBL] [Abstract][Full Text] [Related]
36. Assessing complier average causal effects from longitudinal trials with multiple endpoints and treatment noncompliance: An application to a study of Arthritis Health Journal.
Guo L; Qian Y; Xie H
Stat Med; 2022 Jun; 41(13):2448-2465. PubMed ID: 35274333
[TBL] [Abstract][Full Text] [Related]
37. Bayesian hierarchical models for cost-effectiveness analyses that use data from cluster randomized trials.
Grieve R; Nixon R; Thompson SG
Med Decis Making; 2010; 30(2):163-75. PubMed ID: 19675321
[TBL] [Abstract][Full Text] [Related]
38. Individual allocation had an advantage over cluster randomization in statistical efficiency in some circumstances.
Hewitt CE; Torgerson DJ; Miles JN
J Clin Epidemiol; 2008 Oct; 61(10):1004-8. PubMed ID: 18411038
[TBL] [Abstract][Full Text] [Related]
39. Five interval estimators for proportion ratio under a stratified randomized clinical trial with noncompliance.
Lui KJ; Chang KC
Biom J; 2007 Aug; 49(4):613-26. PubMed ID: 17634977
[TBL] [Abstract][Full Text] [Related]
40. What are the statistical implications of treatment non-compliance in cluster randomized trials: A simulation study.
Moerbeek M; Schie SV
Stat Med; 2019 Nov; 38(26):5071-5084. PubMed ID: 31578760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
